Trial Profile
Comparison between frovatriptan plus different treatment regimens of dexketoprofen (25 mg and 37.5 mg) and frovatriptan alone in the acute treatment of migraine without aura and migraine with aura attacks.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jul 2015
Price :
$35
*
At a glance
- Drugs Dexketoprofen (Primary) ; Frovatriptan
- Indications Migraine
- Focus Therapeutic Use
- 30 Jun 2013 Results presented at the 2013 International Headache Congress .
- 27 Jun 2013 Results from a pre-defined subgroup analysis (women with menstrual-related migraine) presented at the 2013 International Headache Congress .
- 16 Jun 2011 New trial record